SEPTInvestingStart Free
Stocks/OBIO/SEC Filings/8-K Nov 9, 2026

OBIO 8-K: Secondary offering

Orchestra BioMed Holdings, Inc.

Filed with the SEC on Nov 9, 2026 · accession 0001104659-26-124502

OBIO filed a 8-K (current report) with the SEC on Nov 9, 2026. Orchestra BioMed Holdings, Inc. entered into an underwriting agreement for an underwritten public offering of 15,000,000 shares of common stock at $5.00 per share, with the underwriters exercising their option for an additional 2,250,000 shares in full. The stock moved +0.4% by the first close after the filing.

Summary of the filing

Orchestra BioMed Holdings, Inc. entered into an underwriting agreement for an underwritten public offering of 15,000,000 shares of common stock at $5.00 per share, with the underwriters exercising their option for an additional 2,250,000 shares in full. Gross proceeds were approximately $86.3 million, intended to fund clinical programs and general corporate purposes.

For details, click here →How to read a 8-K →

Key details

Gross proceeds from offering$86.3M
Public offering price per share$5
Number of shares offered (including option exercise)shares 17.3M
IssuerOrchestra BioMed Holdings, Inc.
UnderwriterPiper Sandler & Co.
UnderwriterTD Securities (USA) LLC

How OBIO stock reacted

Close before

$5.68

Nov 6, 2026

First close after

+0.35%

$5.70

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for OBIO, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for OBIO?

Click here

Frequently asked questions

What did OBIO file with the SEC on Nov 9, 2026?

OBIO filed a 8-K (Secondary offering). Orchestra BioMed Holdings, Inc. entered into an underwriting agreement for an underwritten public offering of 15,000,000 shares of common stock at $5.00 per share, with the underwriters exercising their option for an additional 2,250,000 shares in full. Gross proceeds were approximately $86.3 million, intended to fund clinical programs and general corporate purposes.

What does a secondary offering mean for OBIO stock?

New shares dilute existing holders and are often sold at a discount to the market price.

How do I read a 8-K?

A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

How did OBIO stock react to this filing?

OBIO closed at $5.68 before the filing and $5.70 on Nov 9, 2026 (+0.35%).

Other OBIO SEC filings

  • 424B5 · Secondary offeringNov 6, 2026
  • 424B5 · Secondary offeringNov 5, 2026
  • 8-K · SEC filingOct 1, 2026
  • 8-K · SEC filingSep 8, 2026
  • 10-Q · SEC filingAug 10, 2026
  • 8-K · SEC filingJun 23, 2026
  • 10-Q · SEC filingMay 12, 2026
  • DEF 14A · Board changeApr 29, 2026

Get alerts when OBIO files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
OBIO overviewOBIO analysisOBIO newsLatest SEC filings
Source: SEC EDGAR filing 0001104659-26-124502. The summary and key details are extracted by SEPT from the filing and may contain errors. Price reaction uses daily closing prices. Not financial advice.